Isabella Caligiuri - Concepedia

Author

Isabella Caligiuri

Ca' Foscari University of Venice ORCID

Also Known As

Caligiuri, Isabella, Flavio Rizzolio, I Caligiuri, I. Caligiuri, Isabella Caligiuri, isabella Caligiuri

126

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Ca' Foscari University of Venice Centro di Riferimento Oncologico Istituti di Ricovero e Cura a Carattere Scientifico University of Pisa University of Trieste

About

Isabella Caligiuri is an author at Ca' Foscari University of Venice specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	729
2	Natural Sciences	10	10	322
3	Biochemistry	6	6	195
4	Engineering	3	3	121
5	Public Health	1	1	49

Isabella Caligiuri

Publications

Citations

H-Index

Page 1

	Year	Citations
Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models Mohamad Hadla, Stefano Palazzolo, Giuseppe Corona, Nanomedicine	2016	275
Exosomal Doxorubicin Reduces the Cardiac Toxicity of Doxorubicin Giuseppe Toffoli, Mohamad Hadla, Giuseppe Corona, Nanomedicine	2015	146
Palladium(II)‐η<sup>3</sup>‐Allyl Complexes Bearing <i>N</i>‐Trifluoromethyl <i>N</i>‐Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High‐Grade Serous Ovarian Cancer Tumoroids Thomas Scattolin, Enrica Bortolamiol, Fabiano Visentin, Chemistry - A European Journal	2020	93
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 Flavio Rizzolio, Chiara Lucchetti, Isabella Caligiuri, Cell Death and Differentiation Tumor BiologySignal TransductionSignaling PathwayCell RegulationMedicine	2012	75
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy Samer Bayda, Mohamad Hadla, Stefano Palazzolo, Journal of Controlled Release Carbon-based MaterialBottom-up SynthesisNanomaterialsChemistryCarbon Nanoparticles	2017	70
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell lines Thomas Scattolin, Isabella Caligiuri, Luciano Canovese, Dalton Transactions Molecular PharmacologyMedicinal ChemistryCross-coupling ReactionSkov-3 Cell LinesMedicine	2018	66
Identification and characterization of a new reversible MAGL inhibitor Tiziano Tuccinardi, Carlotta Granchi, Flavio Rizzolio, Bioorganic & Medicinal Chemistry Medicinal ChemistryMedicineNatural SciencesMechanism Of ActionPharmacotherapy	2014	58
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, Journal of Medicinal Chemistry	2019	55
An Effective Multi-Stage Liposomal DNA Origami Nanosystem for In Vivo Cancer Therapy Stefano Palazzolo, Mohamad Hadla, Concetta Russo Spena, Cancers Cell-based Drug DeliveryNanomedicineDna NanotechnologyLipid PreparationEngineering	2019	53
Early Warnings by Liver Organoids on Short- and Long-Chain PFAS Toxicity Stefano Palazzolo, Isabella Caligiuri, Matteo Mauceri, Toxics PathologyToxicological MechanismOxidative StressMolecular PharmacologyToxicology	2022	49

Page 1